Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02315703
Brief Title: Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention

First Submitted : December 9, 2014
First Submitted that Met QC Criteria : December 9, 2014
First Posted : December 12, 2014 (Estimate)

Results First Submitted : August 28, 2020
Results First Submitted that Met QC Criteria : October 13, 2020
Results First Posted : November 4, 2020

Certification/Extension First Submitted : February 1, 2017
Certification/Extension First Submitted that Met QC Criteria : February 1, 2017
Certification/Extension First Posted : February 2, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : October 13, 2020
Last Update Posted : November 4, 2020